For product information:
For business and employment inquiries:
OraPharma believes oral health is a vital component of overall health. Our goal
is to exceed customers' expectations by providing exceptional products and solutions
that improve their dental practices and patient care, making OraPharma the oral
health partner of choice for our customers.
In 1996, OraPharma was founded as a specialty pharmaceutical company dedicated to
oral healthcare. Our flagship product, ARESTIN (minocycline HCl)
Microspheres, 1 mg, was approved by the FDA in 2001 and advanced the treatment of
periodontal disease. From 2002 to 2010, OraPharma operated as a subsidiary of Johnson
In 2012, OraPharma was acquired by Valeant Pharmaceuticals International, Inc.,
from a strategic private equity firm. Valeant is a multi-national specialty pharmaceutical
company with a diverse product portfolio focused on branded pharmaceuticals, branded
generics, and over-the-counter (OTC) products. More than ever, Valeant is committed
to building OraPharma into a leader in oral healthcare.